10 healthcare startups that could be M&A targets after Teladoc’s record-breaking $18.5 billion deal for Livongo

Thursday, 13 August 2020, 17:53:53
On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo , a chronic-care company. The record deal is sending shockwaves through an industry that analysts say is ripe for more mergers and acquisitions. Business Insider asked 10 venture capitalists and analysts about the impending consolidation in digital health. They listed 10 startups in mental health, drug research, telehealth, and more that are likely to be acquired or make deals of their own soon. For more stories like this, sign up here for our healthcare newsletter, Dispensed . On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo , a chronic-care company. It’s the biggest deal in digital health history, and it’s sending shockwaves through an industry that’s ripe for more mergers and acquisitions, according to Rock Health, a digital health venture fund and advisory firm. “This announcement is merely the starter’s pistol for an inevitable virtual care platforms race,” wrote Sari Kaganoff, a general manager at Rock Health, in a report on August 6 .
— Business Insider

CVS Becomes First Retailer To Introduce PayPal QR Codes At Checkout

Wednesday, 12 August 2020, 20:00:00
DUBLIN, Aug. 12, 2020 /PRNewswire/ — ResearchAndMarkets.com published a new article on the contactless payment industry CVS Becomes First Retailer To Introduce PayPal QR Codes At Checkout CVS will become the first retailer to introduce PayPal QR code technology at checkout in its 8,200…
— PR Newswire

CVS Health Corporation Announces Cash Tender Offers for Certain Outstanding Notes

Wednesday, 12 August 2020, 14:25:00
WOONSOCKET, R.I., Aug. 12, 2020 /PRNewswire/ — CVS Health Corporation (“CVS Health”, NYSE: CVS) announced today that it has commenced cash tender offers (each, a “Tender Offer” and collectively, the “Tender Offers”) for (i) up to $3,000,000,000 aggregate principal amount (the “2023 Notes…
— PR Newswire

Analyst Breaks Down CVS Health’s ‘Complicated’ Quarter

Tuesday, 11 August 2020, 19:31:29
CVS Health Corp’s (NYSE: CVS ) second-quarter earnings report can be defined as “more good than bad” yet the stock still trades at a discounted valuation, according to BofA Securities. The CVS Analyst: Michael Cherny maintains a Buy rating on CVS with an $80 price target. The CVS Thesis: The second-quarter report, which was released on Aug 5., was mixed as the Health Care Benefits unit reported an EBIT that was 48% higher than expected, the Pharmacy Services unit outperformed by 7%, but the Retail/Long Term Care underperformed by around 16%. However, Cherny said the Pharmacy Services business underperformed compared to other analysts’ expectations, making it the “most complicated quarter in the history of the market to model.” Looking forward, it’s difficult to determine an appropriate baseline for CVS and … Full story available on Benzinga.com
— Benzinga

CVS Health : Salesforce, CVS to Collaborate on Covid-19 Workplace Programs | MarketScreener

Monday, 10 August 2020, 14:28:02
By Matt Grossman Salesforce.com Inc. and CVS Health Corp. said Monday they will collaborate on services to help workplaces and campuses return to in-person operations following… | August 10, 2020
— MarketScreener